UltraDx Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $13.7M

  • Investors
  • 2

UltraDx General Information

Description

Developer of early disease diagnosis and precision medicine intended to detect early cancer and provide treatment. The company focuses on the development and commercialization of diagnostic products and services, particularly in the fields of neurology, oncology, immunology, cardiovascular diseases, and infectious diseases. The company leverages digital single-molecule immune detection technology to develop products, aiming to develop early disease detection and treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 707, No. 781, Cai Lun Road
  • China Free Trade Pilot Zone
  • Shanghai, 201203
  • China
+86 139
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Room 707, No. 781, Cai Lun Road
  • China Free Trade Pilot Zone
  • Shanghai, 201203
  • China
+86 139

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UltraDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 08-Nov-2023 $13.7M Completed Startup
To view UltraDx’s complete valuation and funding history, request access »

UltraDx Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
GuangFa Asset Management Venture Capital Minority
To view UltraDx’s complete investors history, request access »

UltraDx FAQs

  • When was UltraDx founded?

    UltraDx was founded in 2022.

  • Where is UltraDx headquartered?

    UltraDx is headquartered in Shanghai, China.

  • What industry is UltraDx in?

    UltraDx’s primary industry is Biotechnology.

  • Is UltraDx a private or public company?

    UltraDx is a Private company.

  • What is UltraDx’s current revenue?

    The current revenue for UltraDx is .

  • How much funding has UltraDx raised over time?

    UltraDx has raised $13.7M.

  • Who are UltraDx’s investors?

    ARCH Venture Partners and GuangFa Asset Management have invested in UltraDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process